DekaBank Deutsche Girozentrale’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-14,450
| Closed | -$130K | – | 1376 |
|
|
2020
Q3 | $130K | Buy |
+14,450
| New | +$130K | ﹤0.01% | 1099 |
|
|
2019
Q4 | – | Sell |
-14,850
| Closed | -$180K | – | 1258 |
|
|
2019
Q3 | $180K | Sell |
14,850
-14,850
| -50% | -$180K | ﹤0.01% | 869 |
|
|
2019
Q2 | $283K | Buy |
29,700
+11,550
| +64% | +$110K | ﹤0.01% | 979 |
|
|
2019
Q1 | $445K | Buy |
18,150
+3,300
| +22% | +$80.9K | ﹤0.01% | 924 |
|
|
2018
Q4 | $227K | Sell |
14,850
-3,300
| -18% | -$50.4K | ﹤0.01% | 949 |
|
|
2018
Q3 | $445K | Sell |
18,150
-500
| -3% | -$12.3K | ﹤0.01% | 945 |
|
|
2018
Q2 | $378K | Buy |
18,650
+500
| +3% | +$10.1K | ﹤0.01% | 967 |
|
|
2018
Q1 | $337K | Sell |
18,150
-500
| -3% | -$9.28K | ﹤0.01% | 933 |
|
|
2017
Q4 | $325K | Hold |
18,650
| – | – | ﹤0.01% | 888 |
|
|
2017
Q3 | $325K | Hold |
18,650
| – | – | ﹤0.01% | 894 |
|
|
2017
Q2 | $340K | Hold |
18,650
| – | – | ﹤0.01% | 882 |
|
|
2017
Q1 | $428K | Sell |
18,650
-1,500
| -7% | -$34.4K | ﹤0.01% | 761 |
|
|
2016
Q4 | $696K | Buy |
20,150
+1,500
| +8% | +$51.8K | 0.01% | 603 |
|
|
2016
Q3 | $449K | Hold |
18,650
| – | – | 0.01% | 684 |
|
|
2016
Q2 | $445K | Buy |
18,650
+3,700
| +25% | +$88.3K | 0.01% | 699 |
|
|
2016
Q1 | $331K | Sell |
14,950
-2,400
| -14% | -$53.1K | ﹤0.01% | 736 |
|
|
2015
Q4 | $529K | Buy |
17,350
+102
| +0.6% | +$3.11K | 0.01% | 691 |
|
|
2015
Q3 | $685K | Buy |
17,248
+2,798
| +19% | +$111K | 0.01% | 616 |
|
|
2015
Q2 | $998K | Buy |
14,450
+500
| +4% | +$34.5K | 0.01% | 569 |
|
|
2015
Q1 | $763K | Buy |
13,950
+750
| +6% | +$41K | 0.01% | 616 |
|
|
2014
Q4 | $568K | Buy |
13,200
+300
| +2% | +$12.9K | 0.01% | 665 |
|
|
2014
Q3 | $412K | Buy |
12,900
+300
| +2% | +$9.58K | 0.01% | 700 |
|
|
2014
Q2 | $261K | Sell |
12,600
-900
| -7% | -$18.6K | ﹤0.01% | 719 |
|
|
2014
Q1 | $261K | Buy |
13,500
+1,100
| +9% | +$21.3K | ﹤0.01% | 679 |
|
|
2013
Q4 | $286K | Buy |
12,400
+300
| +2% | +$6.92K | ﹤0.01% | 619 |
|
|
2013
Q3 | $260K | Buy |
+12,100
| New | +$260K | ﹤0.01% | 626 |
|